Companion Spine
New York, US · Founded 2020
Biotech
Founders & leadership
AG
Anthony G ViscogliosiExecutive Officer, Director
JV
John ViscogliosiDirector
MR
Marc R ViscogliosiDirector
Reported raises · per SEC filings
Form D private placements▶$8.5MraisedFeb 2024 · 1 investors · PharmaceuticalsRule 506(b)
▶$8.5MraisedFeb 2024 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Anthony G ViscogliosiExecutive Officer, Director
- John ViscogliosiDirector
- Marc R ViscogliosiDirector
- Offering amount
- $20M
- Amount sold
- $8.5M
- First sale
- Nov 2023
- Incorporated
- Limited Liability Company, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.